ORIGINAL RESEARCH
Accepted on 30 Sep 2025
Integrative Bioinformatics and Experimental Validation Unveil CRISP3 as a Hypoxia-, Epithelial Mesenchymal Transition-, and Immune-Related Prognostic Biomarker and Therapeutic Target in Breast Cancer
doi 10.3389/fimmu.2025.1634399